PolyMedica to Report Third Quarter Fiscal 2005 Results on February 8,

    Business Editors

    WOBURN, Mass.--(BUSINESS WIRE)--Jan. 12, 2005--PolyMedica Corporation (NNM: PLMD) will announce its Third Quarter Fiscal 2005 Financial Results for the period ended December 31, 2004 on Tuesday, February 8, 2005 after the market closes. The Company will hold a conference call and live webcast later that afternoon at 4:30 p.m., EST.

WHAT: PolyMedica Conference Call to Discuss Third Quarter Fiscal 2005 Results (for the period ended December 31, 2004)

WHEN: Tuesday, February 8, 2005 at 4:30 p.m. (EST)

LIVE WEBCAST: Available on www.polymedica.com and www.fulldisclosure.com

REPLAY: Available via webcast for 90 days at www.polymedica.com and www.fulldisclosure.com

    About PolyMedica (www.polymedica.com)

    PolyMedica Corporation is a leading provider of healthcare products and services to patients suffering from chronic diseases. With over 650,000 active patients, the Company is the nation's largest provider of blood glucose testing supplies and services to people with diabetes. In addition, PolyMedica provides its patients with a full range of prescription medications through its mail-order pharmacy and a nationwide network of over 40,000 retail pharmacies that honor its drug discount card.
    PolyMedica's Liberty Healthcare division focuses on patients who suffer from diabetes and respiratory ailments. Liberty works with patients to identify their needs, and delivers products and services directly to their homes. By frequently communicating with patients and providing the convenience of home delivery, Liberty improves patients' compliance with their physicians' orders and enhances the quality of their lives.

    "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding PolyMedica's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. A discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, are detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 2004 and its Quarterly Reports on Form 10-Q for the periods ended June 30, 2004 and September 30, 2004.

--30--KK/ny*

CONTACT: PolyMedica Corporation Investors: Fred ("Skip") Croninger, 781-933-2020 or Citigate Sard Verbinnen Media: Jim Barron / Denise DesChenes, 212-687-8080

KEYWORD: MASSACHUSETTS INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY EARNINGS CONFERENCE CALLS SOURCE: PolyMedica Corporation

Copyright Business Wire 2005